ALZAMEND NEURO INC (ALZN) Institutional Ownership Changes & 13F Activity
ALZAMEND NEURO INC (ALZN). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Kmt Wealth Management, Llc, Geode Capital Management, Llc, Morgan Stanley, Clearstead Advisors, Llc, and Citigroup Inc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Ifg Advisory, Llc | Buy | +22 | — | 22 | $26.00 | Q2 2026 | Aug 14, 2026 |
| Vanguard Capital Management Llc | Buy | +3,156 | +71.7% | 7,556 | $9.07K | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Sell | -2,152 | -47.8% | 2,352 | $2.82K | Q2 2026 | Aug 13, 2026 |
| Geode Capital Management, Llc | Sell | -19,309 | -42.3% | 26,371 | $31.64K | Q2 2026 | Aug 12, 2026 |
| Tower Research Capital Llc (Trc) | Sell | -2,667 | -43.1% | 3,517 | $4.22K | Q2 2026 | Aug 11, 2026 |
| Kmt Wealth Management, Llc | Buy | +1,329,100 | — | 1,329,100 | $1.59M | Q2 2026 | Aug 05, 2026 |
| Caitong International Asset Management Co., Ltd | Sell | -1 | -25.0% | 3 | $4.00 | Q2 2026 | Aug 05, 2026 |
| Morgan Stanley | Sell | -18,000 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Citigroup Inc | Sell | -5,231 | -100.0% | 0 | $0.00 | Q2 2026 | May 11, 2026 |
| Clearstead Advisors, Llc | Sell | -10,000 | -100.0% | 0 | $0.00 | Q2 2026 | May 06, 2026 |
Frequently asked questions about ALZN activity
Which institutional owners are buying ALZN?
Institutional owners buying ALZN include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ALZN activity?
"Buy" means an investor increased their reported position in ALZN compared to the prior reporting period. This reflects growing exposure to ALZAMEND NEURO INC (ALZN) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ALZN increasing?
Institutional interest in ALZN can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related ALZN Institutional Insights
- ALZN Overview
- ALZN 13F Institutional Holders
- ALZN Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ALZN Insider Trading & SEC Form 4 Activity
- ALZN Articles
- Top Institutional Investor Stock Rankings